US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars
5/18/2015 | published by: Access China Management Consulting Ltd.
... is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration officially issued a technical guidance for development and evaluation of biosimilars and defined the pathway of license approval for biosimilars. Chinese pharmaceutical ...  |  read more...
USD 750
Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020
5/15/2015 | published by: MarketsandMarkets
... in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine, decreasing prices of DNA ...  |  read more...
USD 4,650
Market Access Excellence for Emerging Markets
5/15/2015 | published by: FirstWord
... Access Excellence for Emerging Markets analyses the pricing and market access issues you must understand now in critical, high-growth markets around the globe. Gain insights on the ever-shifting payer landscape and be better prepared to ...  |  read more...
USD 2,100
Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019
5/11/2015 | published by: MarketsandMarkets
... The global mycoplasma testing market is expected to reach $613.49 million by 2019 from $340.29 million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. The mycoplasma testing product segments included in ...  |  read more...
USD 4,650
Research and Development in the Physical, Engineering, and Life Sciences - The 2015 U.S. Market Research Report
6/1/2015 | published by: Kentley Insights
... Engineering, and Life Sciences industry in the United States. These Market Research Reports are based on billions of data points created from millions of annual comprehensive business surveys. Used for a range of strategic purposes, ...  |  read more...
USD 195
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - The 2015 U.S. Market Research Report
6/1/2015 | published by: Kentley Insights
... the Physical, Engineering, and Life Sciences (except Biotechnology) industry in the United States. These Market Research Reports are based on billions of data points created from millions of annual comprehensive business surveys. Used for a ...  |  read more...
USD 195
Bacterial Partnering Terms and Agreements
5/1/2015 | published by: Current Partnering
... terms for headline, upfront and royalty by stage of development Bacterial partnering agreement structure Bacterial partnering contract documents Top bacterial deals by value Most active bacterial dealmakers The Bacterial Partnering Terms and Agreements report provides ...  |  read more...
USD 1,795
Obesity Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... by company A-Z, industry sector, stage of development, technology type Obesity Partnering 2009-2014 provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ...  |  read more...
USD 995
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Expanded Access Programs: Opportunities and Challenges for Pharma
4/15/2015 | published by: FirstWord
... clinicians and patients, this highly-emotive area has both benefits and risks for pharma. What are the advantages? Where are the dangers? Does pharma have a moral imperative to engage? Expanded Access Programs: Opportunities and Challenges ...  |  read more...
USD 595
Scientific Research and Development in Bulgaria – 2015
4/24/2015 | published by: SeeNews - Research & Profiles
... industry sectors - Top companies by share of total number employees in the industry III. MARKET SIZE - Top companies by revenue in the industry sectors - Top companies ranked by total revenue. - Top ...  |  read more...
USD 340
Retinopathy Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 795
Viral Partnering Terms and Agreements
5/1/2015 | published by: Current Partnering
... terms for headline, upfront and royalty by stage of development Viral partnering agreement structure Viral partnering contract documents Top viral deals by value Most active viral dealmakers The Viral Partnering Terms and Agreements report provides ...  |  read more...
USD 1,795
Parasitic Disease Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Parasitic Partnering 2010-2015 provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 795
Clostridium difficile Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Clostridium difficile Partnering 2010-2015 provides understanding and access to the Clostridium difficile partnering deals and agreements entered into by ...  |  read more...
USD 795
Ebola Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Ebola Partnering 2010-2015 provides understanding and access to the ebola partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 795
Drug Addiction Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... by value •Deals listed by company A-Z, industry sector, stage of development, technology type Drug Addiction Partnering 2009-2014 provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds ...  |  read more...
USD 795
Global Encephalitis Vaccination Industry Report - 2015
5/1/2015 | published by: QYResearch Group
... and industry chain structure. The Encephalitis Vaccination market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing ...  |  read more...
USD 2,600
Deal Trends in Diabetes
4/30/2015 | published by: IMS Health
... lucrative sector of diabetes. Data and analysis presented in the report is based on the IMS PharmaDeals database, the leading source of deals and alliances information in the life science industry. Use this report to: ...  |  read more...
USD 2,100
Huntington's Disease Therapeutics
3/1/2015 | published by: Global Industry Analysts
... are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on ...  |  read more...
USD 4,500
Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2015-2025
3/5/2015 | published by: Visiongain
... outlooks from 2015. You see results, trends, opportunities and revenue forecasting. Visiongain’s new study analyses 25 leading developers, producers and marketers of biosimilars. That work also covers other firms, including big pharma companies entering that ...  |  read more...
USD 2,788
PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023
3/1/2015 | published by: GlobalData
... the body can no longer produce insulin. Over the last 90 years, insulin therapy has been evolving continuously, as at present, no other treatment can be offered to a patient who is newly diagnosed with ...  |  read more...
USD 10,995
Global HER-2 Positive Breast Cancer Market 2015-2019
3/4/2015 | published by: TechNavio - Infiniti Research Ltd.
... incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated carcinoma. Breast cancer is the second most common form of cancer ...  |  read more...
USD 3,000
Dermatitis Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dermatitis Partnering 2010-2015 provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds ...  |  read more...
USD 795
The Most Lucrative Market for CROs in the Asia Pacific in 2015
3/4/2015 | published by: Frost & Sullivan
... and 15% of R&D spending. As incomes slowly continue to rise, demand in Asian countries will grow and the region will become an increasingly important market for pharmaceuticals. Drug companies in Asia are currently affected ...  |  read more...
USD 450
< prev 1    3  4  5  6  7  8  9  10